Coping with U.S. Regulation of International Conduct: Compliance Strategies for the Foreign Corrupt Practices Act
November 1, 2009
In recent years, the U.S. Government has become increasingly aggressive in enforcing U.S. laws designed to regulate the conduct of U.S. citizens and companies operating abroad. As a result, multinational firms face multiplying compliance concerns, especially with regard to the Foreign Corrupt Practices Act, export control and sanction regulations, the anti-boycott law, and anti-money laundering requirements. In the first of three articles, the author presents compliance strategies for corporations attempting to manage the risks posed by the Foreign Corrupt Practices Act.
Author(s)
Related Insights
July 15, 2025
Innovative Technology Insights
Navigating FDA’s Proposed Guidance on AI and Non-Animal Models: Safeguarding Innovation in Drug Development
In April 2025, the U.S. Food and Drug Administration (FDA) released a landmark guidance titled “Roadmap to Reducing Animal Testing in…
July 15, 2025
Health Care Law Today
Navigating FDA’s Proposed Guidance on AI and Non-Animal Models: Safeguarding Innovation in Drug Development
In April 2025, the U.S. Food and Drug Administration (FDA) released a landmark guidance titled “Roadmap to Reducing Animal Testing in…
July 15, 2025
Health Care Law Today
Colorado Medicaid: RAC Program Overhauled with Enhanced Transparency, Greater Provider Protections, and Increased Oversight
In June 2025, Colorado passed a new law that makes significant changes to the state’s Medicaid Recovery Audit Contractor (RAC) program….